Tvardi Therapeutics, Inc. Annual Operating Lease, Payments in USD from 2022 to 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Tvardi Therapeutics, Inc. annual/quarterly Operating Lease, Payments history and growth rate from 2022 to 2024.
  • Tvardi Therapeutics, Inc. Operating Lease, Payments for the quarter ending September 30, 2024 was $4.36M, a 773% increase year-over-year.
  • Tvardi Therapeutics, Inc. annual Operating Lease, Payments for 2024 was $4.36M, a 119% increase from 2023.
  • Tvardi Therapeutics, Inc. annual Operating Lease, Payments for 2023 was $1.99M, a 1.79% increase from 2022.
Operating Lease, Payments, Trailing 12 Months (USD)
Operating Lease, Payments, Annual (USD)
Operating Lease, Payments, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $4.36M +$2.37M +119% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-11
2023 $1.99M +$35K +1.79% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-11
2022 $1.96M Jan 1, 2022 Dec 31, 2022 10-K 2024-03-06
* An asterisk sign (*) next to the value indicates that the value is likely invalid.